Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Zhicheng Technology is a medical technology company specializing in digital pathology and artificial intelligence-driven diagnostic solutions. Based in Hangzhou, China, the company develops high-throughput digital pathology scanners and integrated software platforms for image management and telepathology. Their core innovation lies in AI-driven diagnostic modules that assist pathologists in identifying and quantifying biomarkers for various cancers, including cervical, breast, and lung malignancies. By automating routine screening and providing precise quantitative analysis, Zhicheng Technology aims to enhance diagnostic accuracy and efficiency in clinical workflows. The company's products are widely used in hospitals and research institutions to address the shortage of pathology resources and improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Zhicheng Technology.